Literature DB >> 10771399

Molecular characterization of cold agglutinins.

K N Potter1.   

Abstract

An unusual bias involving the exclusive usage of the V4-34 gene segment by pathogenic antibodies with I/i antigen specificity has been documented in the literature. In addition, all unmutated and several mutated V4-34 encoded antibodies have been shown to be reactive with the anti-idiotypic monoclonal antibody 9G4. The 9G4 Id, therefore, is a marker for V4-34 gene segment expression. Based on these two correlations, it became vital to localize and characterize the nature of the 9G4 Id and to determine the relationship between the Id and I binding. Mutational analysis indicated that the 9G4 Id is located in framework region 1 (FR1) of V4-34 encoded antibodies. Two distinct sections of FR1, encompassing amino acid residues 6-12 and 23-25, form the 9G4 Id. Mutational analysis demonstrated that both FR1 and CDRH3 were required for I binding. When either one was disrupted, the mutant antibody could not bind I. This indicates that I binds through a framework region, and not exclusively through CDRH3. This renders the I interaction with the V4-34 encoded portion of immunoglobulins unconventional, with characteristics similar to superantigen binding to immunoglobulin through FR. When the FR1 DNA sequence of V4-34 was exchanged for FR1 sequences from other VH families I binding was lost, providing a structural explanation for this restricted VH usage. An understanding of the localization and structure of the 9G4 Id and the requirements of V4-34 encoded antibodies for I binding provide insights into the structure of pathogenic antibodies and their requirements for binding antigen. This information should be useful in analyzing new interactions such as the lytic activity of some V4-34 encoded antibodies for B cells.

Mesh:

Substances:

Year:  2000        PMID: 10771399     DOI: 10.1016/s0955-3886(00)00031-x

Source DB:  PubMed          Journal:  Transfus Sci        ISSN: 0955-3886


  10 in total

1.  Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity.

Authors:  Agnieszka Małecka; Gunhild Trøen; Anne Tierens; Ingunn Østlie; Jędrzej Małecki; Ulla Randen; Sigbjørn Berentsen; Geir E Tjønnfjord; Jan M A Delabie
Journal:  Haematologica       Date:  2016-05-19       Impact factor: 9.941

2.  Mycoplasma suis antigens recognized during humoral immune response in experimentally infected pigs.

Authors:  L E Hoelzle; K Hoelzle; M Ritzmann; K Heinritzi; M M Wittenbrink
Journal:  Clin Vaccine Immunol       Date:  2006-01

3.  Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasaki disease.

Authors:  Arthur J Chang; Sarah Baron; Jonathon Hoffman; Mark D Hicar
Journal:  Mol Immunol       Date:  2022-03-15       Impact factor: 4.174

4.  Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma.

Authors:  Ulla Randen; Gunhild Trøen; Anne Tierens; Chloé Steen; Abdirashid Warsame; Klaus Beiske; Geir E Tjønnfjord; Sigbjørn Berentsen; Jan Delabie
Journal:  Haematologica       Date:  2013-10-18       Impact factor: 9.941

5.  Cold autoimmune haemolytic anaemia secondary to Epstein Barr virus infection presenting with peripheral gangrene; case report.

Authors:  Suneth Karunarathne; Sajitha Weerasinghe; Dumitha Govindapala; Harshini Fernando; Bhaddika Jayaratne
Journal:  Thromb J       Date:  2012-04-18

Review 6.  HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.

Authors:  Giuseppe Sautto; Nicasio Mancini; Laura Solforosi; Roberta A Diotti; Massimo Clementi; Roberto Burioni
Journal:  Clin Dev Immunol       Date:  2012-05-29

Review 7.  Autoimmune Hemolysis: A Journey through Time.

Authors:  John Freedman
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

Review 8.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

Review 9.  Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).

Authors:  Giuseppe Sautto; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-08       Impact factor: 5.048

Review 10.  Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Authors:  Sigbjørn Berentsen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Hematology       Date:  2007-10       Impact factor: 2.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.